Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Physiotherapy Exercise Programme for Pelvic Floor Function in Healthy Young Women

23. september 2026 opdateret af: María de los Ángeles Sirvent Pinar, Universidad Miguel Hernandez de Elche

A Physiotherapy Exercise Programme Based on Hypopressive Exercise as Adjunctive Muscle Training for the Primary Prevention of Pelvic Floor Dysfunction

This study evaluated the effects of a 12-week physiotherapy exercise programme on pelvic floor and abdominopelvic function in healthy young nulliparous women. Participants were randomly allocated to an intervention group or a control group. The intervention included supervised and home-based exercises focused on postural organization, breathing coordination, and lumbopelvic-abdominal muscle control. The control group continued their usual activities without receiving the study intervention. Pelvic floor muscle function, abdominopelvic functional responses, respiratory function, and health-related quality of life were assessed.

Studieoversigt

Status

Afsluttet

Betingelser

Undersøgelsestype

Interventionel

Tilmelding (Faktiske)

84

Fase

  • Ikke anvendelig

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år til 26 år (Voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Kvinde

Beskrivelse

Inclusion Criteria:

  • Female university students aged 18 to 26 years.
  • Nulliparous.
  • No gynecological pathology.
  • No respiratory pathology.
  • History of sexual intercourse.

Exclusion Criteria:

  • Failure to meet any of the inclusion criteria.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Forebyggelse
  • Tildeling: Randomiseret
  • Interventionel model: Parallel tildeling
  • Maskning: Enkelt

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Intervention Group

Participants assigned to this group completed a 12-week physiotherapy exercise programme focused on postural organization, breathing coordination, and lumbopelvic-abdominal muscle control, combining supervised sessions with home-based exercise.

Participants completed a 12-week exercise programme combining postural organization, breathing coordination, and lumbopelvic-abdominal motor control. The programme included a 20-minute supervised session once weekly, complemented by home-based exercise.

Ingen indgriben: Control group

Participants assigned to this group continued their usual activities and did not receive the study exercise programme during the 12-week study period.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Subumbilical Cough Test
Tidsramme: Baseline and after the 12-week intervention

Qualitative assessment of abdominal wall response during coughing. The outcome was categorized as no bulging or bulging of the abdominal wall. Bulging was defined as caudal bulging of the umbilicopubic region during the cough maneuver, indicating insufficient abdominal muscle activation.

Baseline and after the 12-week intervention

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Pelvic Floor Muscle Strength - Modified Oxford Scale
Tidsramme: Baseline and after the 12-week intervention

Pelvic floor muscle strength was assessed by digital vaginal palpation using the Modified Oxford Scale, scored from 0 to 5, where 0 indicates no perceptible muscle contraction and 5 indicates a strong contraction.

Baseline and after the 12-week intervention
Pelvic Floor Muscle Endurance
Tidsramme: Baseline and after the 12-week intervention

Pelvic floor muscle endurance was assessed by vaginal perineometry. Participants performed three maximal pelvic floor muscle contractions, each maintained for as long as possible. Endurance was recorded as the duration of the sustained contraction, expressed in seconds.

Baseline and after the 12-week intervention
Pelvic Floor Muscle Contraction Pressure
Tidsramme: Baseline and after the 12-week intervention

Pelvic floor muscle contraction pressure was assessed by vaginal perineometry using a pressure probe. Participants performed three maximal pelvic floor muscle contractions, and contraction pressure was recorded in cmH2O.

Baseline and after the 12-week intervention
Abdominal Diastasis Functional Test
Tidsramme: Baseline and after the 12-week intervention

Abdominal wall function was assessed by palpation of the linea alba in the supraumbilical and infraumbilical regions, at rest and during trunk elevation. The test evaluated the presence or absence and location of abdominal diastasis and the response of the linea alba during abdominal muscle activation.

Baseline and after the 12-week intervention
Transversus Abdominis Activation Test
Tidsramme: Baseline and after the 12-week intervention

Abdominal wall response was assessed during maximal inspiration and expiration. During maximal expiration, the outcome was categorized according to whether the abdomen protruded ("pushes") or did not protrude ("does not push"), reflecting the activation response of the transversus abdominis.

Baseline and after the 12-week intervention
Forced Vital Capacity (FVC)
Tidsramme: Baseline and after the 12-week intervention

Forced vital capacity was assessed by forced spirometry using a DATOSPIR-120 spirometer. Three measurements were performed and the best measurement was recorded. FVC was expressed in liters.

Baseline and after the 12-week intervention
Forced Expiratory Volume in One Second (FEV1)
Tidsramme: Baseline and after the 12-week intervention

Forced expiratory volume in one second was assessed by forced spirometry using a DATOSPIR-120 spirometer. Three measurements were performed and the best measurement was recorded. FEV1 was expressed in liters.

Baseline and after the 12-week intervention
Peak Expiratory Flow (PEF)
Tidsramme: Baseline and after the 12-week intervention

Peak expiratory flow was assessed by forced spirometry using a DATOSPIR-120 spirometer. Three measurements were performed and the best measurement was recorded. PEF was expressed in liters per second (L/s).

Baseline and after the 12-week intervention
Health-Related Quality of Life - SF-12
Tidsramme: After the 12-week intervention

Health-related quality of life was assessed using the 12-item Short Form Health Survey (SF-12). Physical and mental health component scores were calculated, with higher scores indicating better perceived health-related quality of life.

After the 12-week intervention

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Efterforskere

  • Ledende efterforsker: Luís Gómez Pérez, PhD, Universidad Miguel Hernández

Publikationer og nyttige links

Den person, der er ansvarlig for at indtaste oplysninger om undersøgelsen, leverer frivilligt disse publikationer. Disse kan handle om alt relateret til undersøgelsen.

Generelle publikationer

  • Sirvent-Pinar MA, Iglesias-Comesaña A, Guerrero-Rubio MA, Alarcón-Alarcón D, Rodríguez-Blanco N, Pérez de Arrilucea Le Floc'h U. Development and reproducible description of a multimodal physiotherapy intervention for pelvic floor health: a methodological report. BMC Women's Health. 2026. doi:10.1186/s12905-026-04779-3.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

1. november 2016

Primær færdiggørelse (Faktiske)

1. maj 2017

Studieafslutning (Faktiske)

1. maj 2017

Datoer for studieregistrering

Først indsendt

23. september 2026

Først indsendt, der opfyldte QC-kriterier

23. september 2026

Først opslået (Faktiske)

30. september 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

30. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

23. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Andre undersøgelses-id-numre

  • DPC.LGP.01.17

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

INGEN

IPD-planbeskrivelse

No prospective plan for individual participant data sharing was established for this study.

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner